Back to Search
Start Over
Deregulation of immune response genes in patients with Epstein-Barr virus-associated gastric cancer and outcomes
- Source :
- Gastroenterology. 148(1)
- Publication Year :
- 2014
-
Abstract
- Patients with Epstein-Barr virus-associated gastric carcinoma (EBVaGC) have a better prognosis than those with gastric cancer not associated with EBV infection (EBVnGC). This is partly because EBV infection recruits lymphocytes, which infiltrate the tumor. A high degree of tumor heterogeneity is likely to be associated with poor response. We investigated differences in gene expression patterns between EBVaGC and EBVnGC.We used gene expression profile analysis to compare tumor and nontumor gastric tissues from 12 patients with EBVaGC and 14 patients with EBVnGC. Findings were validated by whole transcriptome RNAseq and real-time quantitative polymerase chain reaction analyses. CD3(+) primary T cells were isolated from human blood samples; migration of these cells and of Jurkat cells were measured in culture with EBV-infected and uninfected gastric cancer cells.Based on Pearson correlation matrix analysis, EBVaGCs had a higher degree of homogeneity than EBVnGCs. Although 4550 genes were differentially expressed between tumor and nontumor gastric tissues of patients with EBVnGC, only 186 genes were differentially expressed between tumor and nontumor gastric tissues of patients with EBVaGC (P.001). This finding supports the concept that EBVaGCs have fewer genetic and epigenetic alterations than EBVnGCs. Expression of major histocompatibility complex class II genes and genes that regulate chemokine activity were more often deregulated in EBVaGCs compared with nontumor tissues. In culture, more T cells migrated to EBV-infected gastric cancer cells than to uninfected cells; migration was blocked with a neutralizing antibody against CXCR3 (a receptor for many chemokines).Fewer genes are deregulated in EBVaGC than in EBVnGC. Most changes in EBVaGCs occur in immune response genes. These changes might allow EBVaGC to recruit reactive immune cells; this might contribute to the better outcomes of these patients compared with those with EBVnGC.
- Subjects :
- Epstein-Barr Virus Infections
Receptors, CXCR3
T-Lymphocytes
medicine.disease_cause
Major histocompatibility complex
Real-Time Polymerase Chain Reaction
Transcriptome
Jurkat Cells
Immune system
Stomach Neoplasms
medicine
Tumor Cells, Cultured
Cluster Analysis
Humans
Gene Regulatory Networks
RNA, Messenger
Stomach cancer
Oligonucleotide Array Sequence Analysis
Hepatology
biology
Sequence Analysis, RNA
Gene Expression Profiling
Carcinoma
Gastroenterology
Cancer
medicine.disease
Prognosis
Epstein–Barr virus
Antibodies, Neutralizing
Coculture Techniques
Gene Expression Regulation, Neoplastic
Chemotaxis, Leukocyte
Real-time polymerase chain reaction
Case-Control Studies
Cancer cell
Immunology
biology.protein
Cancer research
Subjects
Details
- ISSN :
- 15280012
- Volume :
- 148
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Gastroenterology
- Accession number :
- edsair.doi.dedup.....f7658810a7c469e935c87691abbf0709